Professor Jonathan Emberson
BA, MSc, PhD
Professor of Medical Statistics and Epidemiology
- MRC Population Health Research Unit Programme Leader
- NDPH Deputy Director of Graduate Studies
- MSc in Global Health Science Module Lead: Clinical Trials and Meta-Analysis
Jonathan is Professor of Medical Statistics and Epidemiology within the Nuffield Department of Population Health. After graduating in Mathematics in 1998, he studied statistics and epidemiology at MSc and PhD level before joining the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) in 2004.
His main research involves studying the causes and prevention of cardiovascular diseases through the design, conduct and analysis of large-scale observational cohort studies, randomised controlled trials, and individual-participant-data meta-analyses of both types of study. In particular, he is the UK Principal Investigator and MRC Population Health Research Unit (MRC-PHRU) Programme Leader for the Mexico City Prospective Study, a blood-based prospective cohort study of 150,000 Mexican adults followed for more than 15 years.
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.
WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group None. et al, (2020), JAMA
Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report.
RECOVERY Collaborative Group None. et al, (2020), N Engl J Med
Cross-sectional associations between central and general adiposity with albuminuria: observations from 400,000 people in UK Biobank.
Zhu P. et al, (2020), Int J Obes (Lond)
Association of blood pressure with cause-specific mortality in Mexican adults
GNATIUC L. et al, (2020), JAMA Network Open
Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report
LANDRAY M. et al, (2020), New England Journal of Medicine